AP-MT group | NAP-MT group | NAP-IVTMT group | ||||||
OR | 95 % CI | OR | 95 % CI | P value | OR | 95 % CI | P value | |
mRS 3–6 at 3 months | 1 | – | 0.56 | 0.26 to 1.20 | 0.14 | 0.41 | 0.20 to 0.84 | 0.01 |
Death at 3 months | 1 | – | 0.41 | 0.16 to 1.03 | 0.61 | 0.25 | 0.10 to 0.61 | 0.01 |
rICH | 1 | – | 1.08 | 0.45 to 2.56 | 0.08 | 1.85 | 0.83 to 4.12 | 0.08 |
sICH | 1 | – | 0.69 | 0.13 to 3.68 | 0.48 | 0.44 | 0.09 to 2.08 | 0.77 |
AP-MT group, anticoagulated patients treated with mechanical thrombectomy alone; mRS, modified Rankin scale; NAP-MT group, non-anticoagulated patients treated with mechanical thrombectomy alone; NAP-IVTMT group, non-anticoagulated patients treated with intravenous therapy and mechanical thrombectomy; rICH, radiological intracranial hemorrhage; sICH, symptomatic intracranial hemorrhage.